Search results for "BREAST-CANCER"

showing 7 items of 27 documents

89 Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89 Zr Radiochemistry

2017

Contains fulltext : 181624.pdf (Publisher’s version ) (Open Access) Immuno-positron emission tomography (immunoPET) with (89)Zr-labeled antibodies has shown great potential in cancer imaging. It can provide important information about the pharmacokinetics and tumor-targeting properties of monoclonal antibodies and may help in anticipating on toxicity. Furthermore, it allows accurate dose planning for individualized radioimmunotherapy and may aid in patient selection and early-response monitoring for targeted therapies. The most commonly used chelator for (89)Zr is desferrioxamine (DFO). Preclinical studies have shown that DFO is not an ideal chelator because the (89)Zr-DFO complex is partly…

Pathologymedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentmonoclonal-antibodiesBiomedical Engineeringrational designPharmaceutical Sciencebifunctional chelating-agentBioengineeringCancer imagingReviewgrowth-factorRare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9]010402 general chemistryMonoclonal antibody01 natural sciencesDose planningp-isothiocyanatobenzyl-desferrioxamineIn vivo[ CHIM.ORGA ] Chemical Sciences/Organic chemistryimmuno-petmedicineIn patient[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biology[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyPharmacologymedicine.diagnostic_test010405 organic chemistrybusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryOrganic Chemistrydrug development3. Good health0104 chemical sciencesDrug developmentPositron emission tomographyRadioimmunotherapyUrological cancers Radboud Institute for Health Sciences [Radboudumc 15]click chemistryCancer researchmetastatic breast-cancerbusinessbearing nude-miceNanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19]BiotechnologyBioconjugate Chemistry
researchProduct

The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy

2014

International audience; A new efficient type of gadolinium-based theranostic agent (AGuIX) has recently been developed for magnetic resonance imaging (MRI)-guided radiotherapy. These new particles consist of a polysiloxane network surrounded by a number of gadolinium chelates, usually 10. Due to their small size (<5 nm), AGuIX typically exhibit biodistributions that are almost ideal for diagnostic and therapeutic purposes. For example, while a significant proportion of these particles accumulate in tumours, the remainder is rapidly eliminated by the renal route. In addition, these particles present no evidence of toxicity, in the absence of irradiation with up to 10 times the planned dose f…

Radiation-Sensitizing Agentsmedicine.medical_treatmentGadoliniumContrast MediaGadoliniumReview Article02 engineering and technologyQUANTUM DOTSIonizing radiation[ SDV.CAN ] Life Sciences [q-bio]/CancerMicechemistry.chemical_compound0302 clinical medicineNuclear magnetic resonanceNeoplasmsIN-VIVOmedicine.diagnostic_testNEUTRON-CAPTURE THERAPYGeneral Medicine021001 nanoscience & nanotechnologyMagnetic Resonance Imaging3. Good health030220 oncology & carcinogenesis/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being0210 nano-technologyMRIMaterials scienceRadiotherapy and OncologySiloxanesMOTEXAFIN GADOLINIUMchemistry.chemical_element[SDV.CAN]Life Sciences [q-bio]/Cancer03 medical and health sciences[SDV.CAN] Life Sciences [q-bio]/CancerSDG 3 - Good Health and Well-beingIn vivoRADIATION-THERAPYmedicineAnimalsHumansBREAST-CANCERRadiology Nuclear Medicine and imagingIrradiationbusiness.industryMagnetic resonance imagingModels TheoreticalRadiation therapychemistryMotexafin gadoliniumGOLD NANOPARTICLESNanoparticlesParticleCONTRAST AGENTSIONIZING-RADIATIONNuclear medicinebusiness
researchProduct

dglars: An R Package to Estimate Sparse Generalized Linear Models

2014

dglars is a publicly available R package that implements the method proposed in Augugliaro, Mineo, and Wit (2013), developed to study the sparse structure of a generalized linear model. This method, called dgLARS, is based on a differential geometrical extension of the least angle regression method proposed in Efron, Hastie, Johnstone, and Tibshirani (2004). The core of the dglars package consists of two algorithms implemented in Fortran 90 to efficiently compute the solution curve: a predictor-corrector algorithm, proposed in Augugliaro et al. (2013), and a cyclic coordinate descent algorithm, proposed in Augugliaro, Mineo, and Wit (2012). The latter algorithm, as shown here, is significan…

Statistics and ProbabilityGeneralized linear modelEXPRESSIONMathematical optimizationTISSUESFortrancyclic coordinate descent algorithmdgLARSFeature selectionDANTZIG SELECTORpredictor-corrector algorithmLIKELIHOODLEAST ANGLE REGRESSIONsparse modelsDifferential (infinitesimal)differential geometrylcsh:Statisticslcsh:HA1-4737computer.programming_languageMathematicsLeast-angle regressionExtension (predicate logic)Expression (computer science)generalized linear modelsBREAST-CANCER RISKVARIABLE SELECTIONDifferential geometrydifferential geometry generalized linear models dgLARS predictor-corrector algorithm cyclic coordinate descent algorithm sparse models variable selection.MARKERSHRINKAGEStatistics Probability and UncertaintyHAPLOTYPESSettore SECS-S/01 - StatisticacomputerAlgorithmSoftware
researchProduct

Abnormal peripubertal development of the rat mammary gland following exposure in utero and during lactation to a mixture of genistein and the food co…

2011

The impact of early exposure to endocrine disruptor mixtures on mammary gland development is poorly known. Here, we identify the effects of a conception to weaning exposure of rats to the phytoestrogen genistein (G) and/or the antiandrogen vinclozolin (V) at 1 mg/kg-d, alone or in association. Using several approaches, we found that G- and GV-exposed rats displayed significantly greater epithelial branching and proliferation, wider terminal end buds than controls at PND35, as well as ductal hyperplasia and periductal fibrosis. Focal branching defects were present in V-exposed rats. An increased ER and AR expression was observed in G- and CV- as compared to V-exposed rats at PND35. Surprisin…

[SDV.BA] Life Sciences [q-bio]/Animal biology[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionreceptorGenisteinmammary gland developmentsprague-dawley ratsToxicologyAntiandrogen[ SDV.BA ] Life Sciences [q-bio]/Animal biologychemistry.chemical_compound0302 clinical medicineLactationSexual MaturationVinclozolinReceptorOxazolesfemale mice0303 health sciences[SDV.BA]Life Sciences [q-bio]/Animal biologyendocrine disruptiondifferentiationGenisteinDrug Combinationsmedicine.anatomical_structuregestational and lactational exposureEndocrine disruptorMaternal ExposureIn utero030220 oncology & carcinogenesisVaginaphytoestrogenFemalemedicine.medical_specialtyanti-androgenbreast-cancer riskmedicine.drug_classgrowthFood ContaminationPhytoestrogensandrogenBiologytransgenic mice03 medical and health sciencesMammary Glands AnimalInternal medicinemedicineAnimalsLactationRats Wistar030304 developmental biologyHyperplasiaBody WeightAndrogen AntagonistsAndrogenRats[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionbisphenol-a alterstumorigenesisEndocrinologychemistrycells[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Abnormal peripubertal development of the rat mammary gland following exposure in utero and during lactation to a mixture of genistein and the food co…

2012

The impact of early exposure to endocrine disruptor mixtures on mammary gland development is poorly known. Here, we identify the effects of a conception to weaning exposure of rats to the phytoestrogen genistein (G) and/or the antiandrogen vinclozolin (V) at 1 mg/kg-d, alone or in association. Using several approaches, we found that G- and GV-exposed rats displayed significantly greater epithelial branching and proliferation, wider terminal end buds than controls at PND35, as well as ductal hyperplasia and periductal fibrosis. Focal branching defects were present in V-exposed rats. An increased ER and AR expression was observed in G- and CV- as compared to V-exposed rats at PND35. Surprisin…

anti-androgenbreast-cancer risk[ SDV.AEN ] Life Sciences [q-bio]/Food and Nutritionreceptorgrowthsprague-dawley ratsandrogendifferentiationendocrine disruptionmammary gland developmenttransgenic mice[SDV.AEN] Life Sciences [q-bio]/Food and Nutritionbisphenol-a alterstumorigenesisgestational and lactational exposurecellsphytoestrogenfemale mice[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
researchProduct

Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

2015

The immunogenicity of malignant cells has recently been acknowledged as a critical determinant of efficacy in cancer therapy. Thus, besides developing direct immunostimulatory regimens, including dendritic cell-based vaccines, checkpoint-blocking therapies, and adoptive T-cell transfer, researchers have started to focus on the overall immunobiology of neoplastic cells. It is now clear that cancer cells can succumb to some anticancer therapies by undergoing a peculiar form of cell death that is characterized by an increased immunogenic potential, owing to the emission of the so-called "damage-associated molecular patterns" (DAMPs). The emission of DAMPs and other immunostimulatory factors by…

medicine.medical_treatmentAPOPTOTIC CALRETICULIN EXPOSUREanti-tumor immunityimmunogenicityPHOTODYNAMIC THERAPY0302 clinical medicinetranslational medicineoncoimmunologyImmunology and AllergyCytotoxic T cellMedicineAnti-tumor immunity; Immunogenicity; Immunotherapy; Molecular medicine; Oncoimmunology; Patient prognosis; Translational medicine; Immunology; Immunology and Allergy0303 health sciencesanti-tumor immunity; immunogenicity; immunotherapy; molecular medicine; oncoimmunology; patient prognosis; translational medicineRIBOSOMAL-PROTEIN DIMERClassificationddc:3. Good health030220 oncology & carcinogenesisImmunogenic cell deathMolecular MedicineimmunotherapyACTIVATING POLYPEPTIDE-IIHIGH HYDROSTATIC-PRESSURElcsh:Immunologic diseases. AllergyANTICANCER IMMUNE-RESPONSESImmunology3122 Cancers610 Medicine & healthpatient prognosis03 medical and health sciencesImmune systemHUMAN TUMOR-CELLSFORMYL PEPTIDE RECEPTORS030304 developmental biologybusiness.industryTranslational medicineBiology and Life SciencesCYTOTOXIC T-LYMPHOCYTESImmunotherapyDendritic cellMolecular medicineNEGATIVE BREAST-CANCERImmunologyCancer cellmolecular dicine3111 Biomedicinebusinesslcsh:RC581-607Frontiers in Immunology
researchProduct

Cell-cycle control in cell-biomaterial interactions

2000

Current biocompatibility testing involves the demonstration of cell proliferation, which is usually interpreted as a sign of positive biocompatibility when the materials sustain cell proliferation. As the field of biomaterials research is rapidly moving toward tissue-engineered devices and hybrid organs, control of cell function has become a main topic. Cell function, which involves specific differentiation pathways, cannot be separated from cell-cycle control. The study of cell-cycle control is an important extension of routine proliferation assays and has extensive roots in developmental and tumor biology. We studied the expression of the tumour suppressor gene p53 and the proliferation-a…

p53BiocompatibilityBiomedical EngineeringFOCAL ADHESION KINASEHUMAN BONEPROTEINBiologyFlow cytometryBiomaterialsFocal adhesionbiomaterials testing methodsmedicineKI-67BREAST-CANCERmedicine.diagnostic_testCell growthINDUCTIONPROLIFERATIONBiomaterialCell cycleCell biologyAPOPTOSISEndothelial stem cellFibronectinDNA-DAMAGEImmunologybiology.proteinendothelial cellcell cycleGROWTH ARRESTJournal of Biomedical Materials Research
researchProduct